Editorial
The usefulness of HinotoriTM which is a surgical support robot system developed in Japan and a challenging case of robot-assisted surgery
Translational Cancer Research
2024;
13
(11)
:5723-5724
.
(30 November 2024)
Original Article
Elucidating the molecular and immune interplay between head and neck squamous cell carcinoma and diffuse large B-cell lymphoma through bioinformatics and machine learning
Translational Cancer Research
2024;
13
(11)
:5725-5750
.
(30 November 2024)
Construction of ferroptosis and pyroptosis model to assess the prognosis of gastric cancer patients based on bioinformatics
Translational Cancer Research
2024;
13
(11)
:5751-5770
.
(30 November 2024)
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma
Translational Cancer Research
2024;
13
(11)
:5771-5783
.
(30 November 2024)
Copper metabolism-related lncRNAs predict prognosis and immune landscape in liver cancer patients
Translational Cancer Research
2024;
13
(11)
:5784-5800
.
(30 November 2024)
Immunogenic cell death-related signature predicts prognosis and immunotherapy efficacy in bladder cancer
Translational Cancer Research
2024;
13
(11)
:5801-5814
.
(30 November 2024)
Determining new disulfidptosis-associated lncRNA signatures pertinent to breast cancer prognosis and immunological microenvironment
Translational Cancer Research
2024;
13
(11)
:5815-5829
.
(30 November 2024)
Pan-cancer analysis combined with experimental validation revealed that KTN1 is an immunological and prognostic biomarker
Translational Cancer Research
2024;
13
(11)
:5830-5844
.
(30 November 2024)
Nomogram for predicting the early death of patients with stage IV ovarian cancer: a retrospective analysis of the SEER database
Translational Cancer Research
2024;
13
(11)
:5845-5855
.
(30 November 2024)
Identification of the CD8+ T-cell exhaustion signature of hepatocellular carcinoma for the prediction of prognosis and immune microenvironment by integrated analysis of bulk- and single-cell RNA sequencing data
Translational Cancer Research
2024;
13
(11)
:5856-5872
.
(30 November 2024)
Development of a risk prediction model for personalized assessment of postoperative recurrence risk in colon cancer patients
Translational Cancer Research
2024;
13
(11)
:5873-5882
.
(30 November 2024)
Prognostic signature detects homologous recombination deficient in glioblastoma
Translational Cancer Research
2024;
13
(11)
:5883-5897
.
(30 November 2024)
The relationship between marital status and survival in primary bone cancer: a population-based study
Translational Cancer Research
2024;
13
(11)
:5898-5908
.
(30 November 2024)
Construction of a disulfidptosis-related lncRNAs signature of the subtype, prognostic, and immunotherapy in neuroblastoma
Translational Cancer Research
2024;
13
(11)
:5909-5928
.
(30 November 2024)
Alpha-fetoprotein-to-PIVKA-II ratio as a potential biomarker for hepatocellular carcinoma differentiation, imaging characteristics, and patient survival
Translational Cancer Research
2024;
13
(11)
:5929-5942
.
(30 November 2024)
Development of prediction models for liver metastasis in colorectal cancer based on machine learning: a population-level study
Translational Cancer Research
2024;
13
(11)
:5943-5952
.
(30 November 2024)
Bioinformatics analysis reveals VEGFC’s prognostic significance in head and neck squamous cell carcinoma and its association with immune cell infiltration
Translational Cancer Research
2024;
13
(11)
:5953-5970
.
(30 November 2024)
Exploring potential causal genetic variants and genes for endometrial cancer: Open Targets Genetics, Mendelian randomization, and multi-tissue transcriptome-wide association analysis
Translational Cancer Research
2024;
13
(11)
:5971-5982
.
(30 November 2024)
Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinoma
Translational Cancer Research
2024;
13
(11)
:5983-5994
.
(30 November 2024)
Prognostic analysis of SYTL4 in acute myeloid leukemia
Translational Cancer Research
2024;
13
(11)
:5995-6003
.
(30 November 2024)
The prognosis and treatment consideration for non-small cell lung carcinoma patients with tumor size of >2.0–3.0 cm and visceral pleural invasion: a SEER-based study
Translational Cancer Research
2024;
13
(11)
:6004-6017
.
(30 November 2024)
Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors
Translational Cancer Research
2024;
13
(11)
:6018-6027
.
(30 November 2024)
Multi-omics decipher the immune microenvironment and unveil therapeutic strategies for postoperative ovarian cancer patients
Translational Cancer Research
2024;
13
(11)
:6028-6044
.
(30 November 2024)
Comparison of postoperative radiotherapy and definitive radiotherapy for non-metastatic adenoid cystic carcinoma of the head and neck, a propensity score matching based on the SEER database
Translational Cancer Research
2024;
13
(11)
:6045-6056
.
(30 November 2024)
SKA1/2/3 link to poor prognosis and immune infiltration of head and neck squamous cell carcinomas
Translational Cancer Research
2024;
13
(11)
:6057-6069
.
(30 November 2024)
Potential role of TWIST1 and its methylation in bladder urothelial carcinoma
Translational Cancer Research
2024;
13
(11)
:6070-6086
.
(30 November 2024)
Neuroepithelial cell transforming 1 as a key regulator in non-small cell lung cancer: unveiling causal links and therapeutic potentials
Translational Cancer Research
2024;
13
(11)
:6087-6104
.
(30 November 2024)
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
Translational Cancer Research
2024;
13
(11)
:6105-6116
.
(30 November 2024)
Construction and validation of a novel prognostic model with palmitoylation-related genes for glioblastoma
Translational Cancer Research
2024;
13
(11)
:6117-6135
.
(30 November 2024)
A novel immune-related gene prognostic signature combining immune cell infiltration and immune checkpoint for glioblastoma patients
Translational Cancer Research
2024;
13
(11)
:6136-6153
.
(30 November 2024)
Epidemiological characteristics of myxopapillary ependymoma and factors affecting overall survival: a SEER-based analysis
Translational Cancer Research
2024;
13
(11)
:6154-6164
.
(30 November 2024)
A lncRNA signature associated with endoplasmic reticulum stress supports prognostication and prediction of drug resistance in acute myelogenous leukemia
Translational Cancer Research
2024;
13
(11)
:6165-6181
.
(30 November 2024)
Integrative multi-omics and machine learning approach reveals tumor microenvironment-associated prognostic biomarkers in ovarian cancer
Translational Cancer Research
2024;
13
(11)
:6182-6200
.
(30 November 2024)
ABALON regulates mitophagy and 5-FU sensitivity in colorectal cancer via PINK1-Parkin pathway
Translational Cancer Research
2024;
13
(11)
:6201-6218
.
(30 November 2024)
The expression and prognostic value of IFIT3 in esophageal squamous cell carcinoma
Translational Cancer Research
2024;
13
(11)
:6219-6234
.
(30 November 2024)
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer
Translational Cancer Research
2024;
13
(11)
:6235-6245
.
(30 November 2024)
Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT’s performance in educating patients and trainees
Translational Cancer Research
2024;
13
(11)
:6246-6254
.
(30 November 2024)
FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis
Translational Cancer Research
2024;
13
(11)
:6255-6272
.
(30 November 2024)
PARP1 promotes tumor proliferation in lenalidomide-resistant multiple myeloma via the downregulation of microRNA-192-5p-AKT signaling
Translational Cancer Research
2024;
13
(11)
:6273-6281
.
(30 November 2024)
Novel cuprotosis-related gene signature: a prognostic indicator and regulator of the glioma immune microenvironment
Translational Cancer Research
2024;
13
(11)
:6282-6297
.
(30 November 2024)
Increased expression of HBXIP (LAMTOR5) predicts poor prognosis and is correlated with immune-cell infiltration in glioma
Translational Cancer Research
2024;
13
(11)
:6298-6314
.
(30 November 2024)
SLC1A3 knockdown in inhibiting the proliferation, apoptosis resistance, and migration of ovarian cancer cells
Translational Cancer Research
2024;
13
(11)
:6315-6322
.
(30 November 2024)
Postexercise downregulation of NUP155 in regulating non-small cell lung cancer progression via the PTEN/AKT signaling pathway
Translational Cancer Research
2024;
13
(11)
:6323-6335
.
(30 November 2024)
The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer
Translational Cancer Research
2024;
13
(11)
:6336-6346
.
(30 November 2024)
CTNND2 gene expression in melanoma tissues and its effects on the malignant biological functions of melanoma cells
Translational Cancer Research
2024;
13
(11)
:6347-6363
.
(30 November 2024)
N-acetyltransferase 10 as a novel prognostic biomarker in papillary renal cell carcinoma: a machine learning and experimental validation study
Translational Cancer Research
2024;
13
(11)
:6364-6380
.
(30 November 2024)
GCNT3 promotes the proliferation, apoptosis, invasion, and migration of breast cancer through the PI3K/AKT pathway
Translational Cancer Research
2024;
13
(11)
:6381-6393
.
(30 November 2024)
Brief Report
Sex-based differences in CEACAM5 expression in lung cancer
Translational Cancer Research
2024;
13
(11)
:6394-6402
.
(30 November 2024)
Review Article
Non-clear cell renal cell carcinoma narrative review: where we are in 2024
Translational Cancer Research
2024;
13
(11)
:6403-6412
.
(30 November 2024)
Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?—a narrative review
Translational Cancer Research
2024;
13
(11)
:6413-6429
.
(30 November 2024)
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men
Translational Cancer Research
2024;
13
(11)
:6430-6437
.
(30 November 2024)
Management of translocation carcinomas of the kidney
Translational Cancer Research
2024;
13
(11)
:6438-6447
.
(30 November 2024)
Adjuvant therapy in renal cell carcinoma (RCC): progress, at last
Translational Cancer Research
2024;
13
(11)
:6448-6462
.
(30 November 2024)
Contemporary surgical management of testicular seminoma
Translational Cancer Research
2024;
13
(11)
:6463-6472
.
(30 November 2024)
Management strategies for radio-recurrent prostate cancer: a comprehensive review
Translational Cancer Research
2024;
13
(11)
:6473-6488
.
(30 November 2024)
Predicting response to bacillus Calmette-Guerin in high-risk non-muscle invasive bladder cancer
Translational Cancer Research
2024;
13
(11)
:6489-6502
.
(30 November 2024)
Treatment approaches for prostate cancer in sub-Saharan Africa
Translational Cancer Research
2024;
13
(11)
:6503-6510
.
(30 November 2024)
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review
Translational Cancer Research
2024;
13
(11)
:6511-6528
.
(30 November 2024)
A narrative clinical trials review in the realm of focal therapy for localized prostate cancer
Translational Cancer Research
2024;
13
(11)
:6529-6539
.
(30 November 2024)
Targeting C797S mutations and beyond in non-small cell lung cancer—a mini-review
Translational Cancer Research
2024;
13
(11)
:6540-6549
.
(30 November 2024)
Targeting breast cancer resistance protein (BCRP/ABCG2) in cancer
Translational Cancer Research
2024;
13
(11)
:6550-6564
.
(30 November 2024)
Immunotherapy for locally advanced and metastatic basal cell carcinoma: a narrative review
Translational Cancer Research
2024;
13
(11)
:6565-6575
.
(30 November 2024)
Case Report
Malignant phyllodes tumor of the breast with bilateral ductal carcinoma in situ and postoperative distant metastasis: a case report
Translational Cancer Research
2024;
13
(11)
:6576-6583
.
(30 November 2024)
Massive gastrointestinal hemorrhage and iodine-125 seed migration due to hepatogastric fistula: a case report and literature review
Translational Cancer Research
2024;
13
(11)
:6584-6589
.
(30 November 2024)
Editorial Commentary
Identifying biomarkers to predict immune-checkpoint therapy response—is it a reality or a distant dream?
Translational Cancer Research
2024;
13
(11)
:6590-6593
.
(30 November 2024)
The next frontier in breast cancer: genomic co-alteration and its impact on biology and treatment planning
Translational Cancer Research
2024;
13
(11)
:6594-6597
.
(30 November 2024)
Retraction
Retraction: Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy
Translational Cancer Research
2024;
13
(11)
:6598
.
(30 November 2024)
